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EDITORIAL
Dear Readers
Welcome to this year’s first edition of JEMDSA. The Chinese 
calendar indicates that we live in the year of the dog. So should 
we expect events of bravery, loyalty and affection to unfold or 
should we anticipate a near-future that is filled with barking 
madness? Yes, the current president of the USA was born in the 
year of this canine!  
Perhaps we should rather reflect on more sedate matters of 
acquiring new knowledge in JEMDSA.     
This edition offers both interesting and insightful perspectives 
on diabetes. The five articles cover a spectrum of new 
information as it pertains to the South African setting. This is 
refreshing (basic sciences and clinical care are addressed) as it 
is strategic (keeping diabetology ex South Africa on the world 
stage). So allow me to offer big handshakes to colleagues from 
1) KZN and Pretoria who submitted excellent manuscripts and 2) 
all those who offered to review these manuscripts, often under 
some duress (cf my Johannesburg colleagues).        
Magnesium deficiency has always reared its head in regard 
to diabetes (risk of disease, glucose control and diabetes 
complication) and Pillay S, et al. offer comment on some of these 
interrelationships. Diabetes in the young, defined here as < 35 
years of age, often begs the clinical question of a type 1 vs. type 2 
diagnosis, and Govender P, et al. provide some clinical evidence 
to this decision. Perhaps someone should pose a question to this 
group and ascertain if the Cluster 1 to 5 diabetes categories as 
proposed by Groop L, et al. conform to a South African cohort? 
Hypoglycaemia has and remains a clinical challenge that should 
be avoided in our quest to attain good glycaemic control. Omar 
M, et al. certainly allude to the very high prospective incidence 
of hypoglycaemia in their study: 98% and 90% in type 1 and 2 
patients, respectively. Thankfully our newer SEMDSA guidelines 
offer treatment options that facilitate good and safer control 
in this regard. Newer basal insulin analogues seem to offer this 
safer (fewer hypoglycaemic episodes) treatment alternative, 
and a basic understanding of insulin pharmacokinetics and 
pharmacodynamics as defined within the parameters of the 
glucose clamp, is important. Oppel B, et al. clarify these concepts 
for us. Cardiovascular disease remains a major source of 
morbidity and mortality in patients with diabetes and the use of 
the resting ECG in identifying high-risk patients, remains unclear. 
Pillay S, et al. suggest that perhaps the routine ECG is not a waste 
of time! 
Happy reading!
Jeffrey  Wing
